THE COMBINATION OF ANTICHOLINERGICS AND LEUKOTRIENE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY DISEASES

摘要

The present invention relates to a combination comprising topical (inhaled) anticholinergics and inhaled or oral leukotriene (LT) receptor antagonists (BLT- and CysLT-receptor antagonists) for the treatment of respiratory diseases including allergic rhinitis, bronchial asthma and chronic obstructive pulmonary diseases (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer~.